AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 FEB 21 - (NewsRx.com & NewsRx.net) --
by Michelle Marble, staff medical writer -- According to a study from the United States, genetic differences in populations influence vaccine efficacy.
"Human leukocyte antigen (HLA) polymorphism can complicate the design and development of vaccines, especially those that contain a selected number of epitopes and are directed at pathogens prevalent worldwide," wrotes D.V. Dawson and colleagues, Case Western Reserve University, Cleveland, Ohio. "Because of HLA class I restricted antigen recognition and ethnic variation in HLA distribution, such vaccines may not be uniformly effective across populations." Dawson et al. published the results of their study in the journal Genetic Epidemiology.
"We, therefore, considered whether it is possible to assemble a panel of HLA-A and/or HLA-B alleles that would allow the formulation of a single vaccine for a set of Caucasian, Black, or Asian populations," continued the authors. "In applying an algorithm to predict levels of favorable response, we identified predominant alleles in 15 representative populations."
The researchers found that roughly 80% of the individuals in one Black-African population and five Asian populations were positive for at least one of three HLA-A alleles. They also determined that 80% coverage was theoretically possible in five Caucasian populations with only five HLA-A alleles. Four of the five Black populations analyzed also required five alleles, but the allelic combinations differed from those in the Caucasian populations.
"Our findings suggest that ...